Targeting the Research and Development of Drugs for New Gene Therapy and Regenerative Medicine -CellGenTech, Inc.-

 

セルジェンテック株式会社
CellGenTech, Inc.

セルジェンテック株式会社イメージ5 セルジェンテック株式会社イメージ1 セルジェンテック株式会社イメージ2 セルジェンテック株式会社イメージ3

JapaneseEnglish

information

CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. We are now performing the translational clinical research for LCAT deficiency as the 1st target and trying to expand this new therapy to other rare diseases.